The research you fund through LCRF is making meaningful progress in the fight against lung cancer. We are pleased to share our 2023 grantees’ one-year updates in this series.
Benjamin Morris, MD
MD Anderson Cancer Center
2023 LCRF Leading Edge Research Grant Program
What he’s doing:
Dr. Morris is leading critical research to better understand how small cell lung cancer (SCLC) responds to treatment by analyzing patient tumor samples before, during, and after therapy—particularly when the cancer progresses. His team is also comparing the genetic makeup of tumors in patients who respond well to treatment versus those whose cancer proves resistant.
What it could mean for patients:
By uncovering the genetic changes that occur throughout treatment, Dr. Morris hopes to identify patterns that could guide the development of more effective therapies for SCLC. Since this type of lung cancer has historically been difficult to treat, understanding its biology is essential to finding new and improved treatment strategies.